Edgewise Therapeutics Statistics

Total Valuation

EWTX has a market cap or net worth of $1.37 billion. The enterprise value is $936.83 million.

Market Cap	1.37B
Enterprise Value	936.83M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

EWTX has 105.20 million shares outstanding. The number of shares has increased by 35.11% in one year.

Current Share Class	105.20M
Shares Outstanding	105.20M
Shares Change (YoY)	+35.11%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	61.37%
Float	62.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.88
P/TBV Ratio	3.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.99, with a Debt / Equity ratio of 0.01.

Current Ratio	20.99
Quick Ratio	20.67
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.29% and return on invested capital (ROIC) is -21.81%.

Return on Equity (ROE)	-30.29%
Return on Assets (ROA)	-21.08%
Return on Invested Capital (ROIC)	-21.81%
Return on Capital Employed (ROCE)	-39.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.33M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.87% in the last 52 weeks. The beta is 0.26, so EWTX's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	-32.87%
50-Day Moving Average	14.70
200-Day Moving Average	24.10
Relative Strength Index (RSI)	35.24
Average Volume (20 Days)	952,829

Short Selling Information

The latest short interest is 12.53 million, so 11.91% of the outstanding shares have been sold short.

Short Interest	12.53M
Short Previous Month	14.31M
Short % of Shares Out	11.91%
Short % of Float	20.03%
Short Ratio (days to cover)	12.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-170.04M
Pretax Income	-115.88M
Net Income	-146.09M
EBITDA	-167.93M
EBIT	-170.04M
Earnings Per Share (EPS)	-$1.55

Full Income Statement

Balance Sheet

The company has $436.39 million in cash and $4.56 million in debt, giving a net cash position of $431.83 million or $4.10 per share.

Cash & Cash Equivalents	436.39M
Total Debt	4.56M
Net Cash	431.83M
Net Cash Per Share	$4.10
Equity (Book Value)	429.72M
Book Value Per Share	4.51
Working Capital	422.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$118.30 million and capital expenditures -$1.06 million, giving a free cash flow of -$119.36 million.

Operating Cash Flow	-118.30M
Capital Expenditures	-1.06M
Free Cash Flow	-119.36M
FCF Per Share	-$1.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EWTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.11%
Shareholder Yield	-35.11%
Earnings Yield	-10.67%
FCF Yield	-8.72%

Analyst Forecast

The average price target for EWTX is $39.89, which is 206.61% higher than the current price. The consensus rating is "Buy".

Price Target	$39.89
Price Target Difference	206.61%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1